Cherubim Interests, Inc. (CHIT) Construction & Real Estate

New Post Public Reply Private Reply Replies (0) Message Board
QualityStocks
Cherubim Interests, Inc. (CHIT) Construction & Real Estate Development Capacities Mesh Seamlessly with BudCube Cultivation Systems’ Offerings

Contrary to one of the leading memes put forth to explain the recent Ohio electoral defeat of Issue 3, which would have made marijuana legal and taxed, this was not really a rejection of the concept itself, so much as the proposed implementation methodology. Cultivation, you see, would’ve been limited to a tiny handful of only ten pre-chosen properties and the formation of Ohioans against Marijuana Monopolies by Democratic Rep. Mike Curtin, which led the charge against this looming threat, was a clear shot across the sector’s bow when it comes to the formation of monopolistic or cartel-like market structures.

The issue of marijuana legalization is far from dead in Ohio and many analysts are chalking up a big portion of the recent down vote to skittishness at plunging into the deep end head first. For unlike other states that approved medical marijuana in advance of legalization, Ohio was attempting to quit prohibition cold turkey.

Legal marijuana is the fastest growing industry in the country right now, with leading sector analysis shop, ArcView Market Research, clearly detailing the case in report after report. ArcView’s State of Legal Marijuana Markets report is now in its third edition and indicates that, in addition to 74 percent market growth last year to around $2.7 billion, the legal marijuana market ceiling (if all states legalized) is currently just under $37 billion. According to analysts at ArcView, fourteen more states are geared up or are gearing up to legalize adult use, and at least two more states are headed toward implementing medical marijuana legislation by 2019. If only this amount of legalization or decriminalization occurs, the market would grow to around $10.8 billion, generating vast sums of tax revenue in the process.

Doubling down on this growing trend towards more sensible marijuana legislation and the taxable, multi-billion dollar industry it is rapidly fueling, is diversified construction, real estate development, and controlled environment agriculture player, Cherubim Interests (OTC: CHIT). With a footprint spanning diverse but synergistic industries, Cherubim is leveraging a unique, hybrid business model in order to maximize shareholder benefit. A model which is driven by alternative commercial, single and multifamily dwelling opportunities on the one hand, and by exploitation of the company’s exclusive worldwide license for proprietary plant cultivation technology, via its wholly-owned BudCube Cultivation Systems USA subsidiary, on the other.

BudCube’s portable, scalable cultivation system allows cultivators quick entry into the market using a logistically more efficient solution than traditional site build out and cultivation system implementations – and at a substantially lower price point to boot. Tag teamed with a real estate development and property management effort, BudCube Cultivation Systems can strike like lightening, and rapidly hit anywhere on earth that cannabis cultivation becomes legalized. Whether it is taking existing square footage and dropping in an array of BudCube’s, or leasing BudCube’s to cultivators as a drop-in, no nonsense solution for easily maintaining crop integrity, yield, and potency – Cherubim Interests is aiming to ride the crest of the green rush all the way to money town.

Investor upside is serious business for CHIT, too, with the recent issuance of a Convertible Preferred Stock Dividend to individual shareholders clearly marking the front end of what is an entire series of carefully planned initiatives designed to bolster stockholder equity. This raft of stimuli is also intended to serve as a schematic moving forward, pulling in more and more investment as Cherubim Interests accelerates into the acquisition of undervalued assets. To wit, on November 5, CHIT initiated a move to fund the acquisition of one or more income producing properties via the issuance of convertible preferred shares, with preferred shareholders receiving dividends that are tied directly to property income.

Cherubim is keeping its lips tightly sealed until negotiations have been finalized, but anticipates disclosing the location of the initial target location within weeks. CEO of CHIT, Patrick Johnson, indicated to markets that the company currently has a number of potential locales in the hopper with strong investment potential, and that the company is now quite busy with the final due diligence on a carefully vetted handful of other targets.

Exciting times for a company like CHIT, with its extensive real estate development know how spanning due diligence, acquisition and planning, as well as construction, renovation, and eventual property management. With its bedrock in handling full-spectrum, start-to-finish development programs on properties for commercial, single and multifamily, as well as mixed use, Cherubim Interests is perfectly positioned to capitalize both on the real estate market, where housing starts were up 6.5 percent in September, with an 18.3 jump in multifamily units (including apartments and condos), and the burgeoning marijuana market.

Learn more about Cherubim Interests by visiting www.cherubiminterests.com

Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com

Cherubim Interests, Inc. (CHIT) Stock Research Links

CHIT Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 19

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 22

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 16

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 9

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 13

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 21

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Niterra and Rackspace: Seamless Migration to Google Cloud

Updated Category News Views 126

Niterra and Rackspace: A Strategic Partnership for Cloud Migration Niterra EMEA GmbH has taken a monumental step in its digital transformation journey by partnering with Rackspace Technology. This collaboration aims to enhance operational efficiency through a swift migration to Google Cloud, capitalizing on Rackspace's extensive expertise in handling business-critical...

Continue Reading
Sweden Procures Four C-390 Millennium Aircraft from Embraer

Updated Category News Views 123

Sweden's Announcement on C-390 Millennium Acquisition In a significant development for military aviation, Sweden has officially committed to acquiring four C-390 Millennium multi-mission aircraft from Embraer. This strategic move is expected to enhance Sweden's defense capabilities and interoperability within NATO. Details of the Agreement The acquisition announcement...

Continue Reading
MindMed Initiates Phase 3 Study for MM120 in Anxiety Treatment

Updated Category News Views 332

MindMed Begins Journey with Phase 3 Study of MM120 Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) has crossed a significant milestone in its mission to provide breakthrough treatments for brain health disorders. The clinical-stage biopharmaceutical company has announced that the first patient is now dosed in its pivotal Phase 3 Voyage study of MM120 Orally Disintegrating...

Continue Reading
Global Office Furniture Market Set to Expand Significantly

Updated Category News Views 62

Growth Overview of the Office Furniture Market The global office furniture market is currently experiencing steady growth, fueled by the rising popularity of flexible and hybrid work environments. This shift is creating a strong demand for adaptable and ergonomic furniture that works well in both home and office contexts. As businesses evolve and expand, there’s an...

Continue Reading
Understanding Fiscal Dominance and Its Impact on Bond Markets

Updated Category News Views 467

Understanding Fiscal Dominance and Its Effects Fiscal dominance is an increasingly important concept in today's economic discussions, especially for those keen on understanding market dynamics. This economic principle involves a scenario where ongoing primary fiscal deficits stimulate nominal growth while the Central Bank maintains a loose monetary policy, failing to...

Continue Reading